心血管

订阅

MedSci主页 / 所有栏目 / 心血管

AJKD：上臂中部周径下降与血液透析患者的全因死亡率和心血管事件明显相关

2013-07-22 MedSci AJKD

全因死亡透析
关注

一项Hemodialysis（HEMO）研究发现，上臂中部周径（MAC）下降与血液透析（HD）患者的全因死亡率和心血管事件明显相关，这种相关性在体重指数（BMI）低的患者中更加显着（BMI≤25）。该研究由新墨西哥大学Mark L. Unruh和同事完成，已在线发表于American Journal of Kidney Diseases 研究概述 研究共纳入1846名HD患者，观察两项营养状态

一项Hemodialysis（HEMO）研究发现，上臂中部周径（MAC）下降与血液透析（HD）患者的全因死亡率和心血管事件明显相关，这种相关性在体重指数（BMI）低的患者中更加显着（BMI≤25）。该研究由新墨西哥大学Mark L. Unruh和同事完成，已在线发表于American Journal of Kidney Diseases

研究概述

研究共纳入1846名HD患者，观察两项营养状态指标——MAC和皮褶厚度的变化与全因死亡率、心血管事件死亡、住院及感染相关死亡的关联。该研究中位随访时间为2.5年，期间发生死亡845例患者MAC和皮褶厚度下降分为0.26厘米和1.1毫米/年。

BMI低的患者中，每年MAC下降1cm将导致HD患者全因死亡率增加2.4倍；在BMI＞25的患者中，二者无明显相关性。不管BMI高低，每年MAC下降1cm可导致心血管死亡和住院分别增加54%和47%。在BMI低的患者中，感染相关死亡增加5倍。在BMI低的患者中，皮褶厚度每降低1mm，全因死亡率增加22%，感染相关死亡增加83%。

研究者指出，高 BMI在透析患者被认为是一个生存的保护性指标，这曾被称为“肥胖悖论”。营养状况不良与透析患者生存率有关。BMI≤25的患者，肌肉含量和身体脂肪的下降可能会影响死亡风险；而在超重或肥胖的HD患者中，没有观察到上述关系。

原始出处：

Su CT, Yabes J, Pike F, Weiner DE, Beddhu S, Burrowes JD, Rocco MV, Unruh ML.Changes in Anthropometry and Mortality in Maintenance Hemodialysis Patients in the HEMO Study.Am J Kidney Dis. 2013 Jul 13. doi:pii: S0272-6386(13)00910-4. 10.1053/j.ajkd.2013.05.015.

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1643317, encodeId=9b09164331e82, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Tue Oct 01 04:29:00 CST 2013, time=2013-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251451, encodeId=9262125145113, content=<a href='/topic/show?id=874529332ba' target=_blank style='color:#2F92EE;'>#全因死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29332, encryptionId=874529332ba, topicName=全因死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Jul 24 04:29:00 CST 2013, time=2013-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262458, encodeId=16f1126245817, content=<a href='/topic/show?id=a57589339a4' target=_blank style='color:#2F92EE;'>#血液透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89339, encryptionId=a57589339a4, topicName=血液透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Wed Jul 24 04:29:00 CST 2013, time=2013-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570574, encodeId=0c2915e0574f4, content=<a href='/topic/show?id=e53d94835a5' target=_blank style='color:#2F92EE;'>#透析患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94835, encryptionId=e53d94835a5, topicName=透析患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0915676167, createdName=ewsr6, createdTime=Wed Jul 24 04:29:00 CST 2013, time=2013-07-24, status=1, ipAttribution=)]
    2013-10-01 hukaixun

    #血管事件#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1643317, encodeId=9b09164331e82, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Tue Oct 01 04:29:00 CST 2013, time=2013-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251451, encodeId=9262125145113, content=<a href='/topic/show?id=874529332ba' target=_blank style='color:#2F92EE;'>#全因死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29332, encryptionId=874529332ba, topicName=全因死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Jul 24 04:29:00 CST 2013, time=2013-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262458, encodeId=16f1126245817, content=<a href='/topic/show?id=a57589339a4' target=_blank style='color:#2F92EE;'>#血液透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89339, encryptionId=a57589339a4, topicName=血液透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Wed Jul 24 04:29:00 CST 2013, time=2013-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570574, encodeId=0c2915e0574f4, content=<a href='/topic/show?id=e53d94835a5' target=_blank style='color:#2F92EE;'>#透析患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94835, encryptionId=e53d94835a5, topicName=透析患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0915676167, createdName=ewsr6, createdTime=Wed Jul 24 04:29:00 CST 2013, time=2013-07-24, status=1, ipAttribution=)]
    2013-07-24 医者仁心

    #全因死亡率#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1643317, encodeId=9b09164331e82, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Tue Oct 01 04:29:00 CST 2013, time=2013-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251451, encodeId=9262125145113, content=<a href='/topic/show?id=874529332ba' target=_blank style='color:#2F92EE;'>#全因死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29332, encryptionId=874529332ba, topicName=全因死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Jul 24 04:29:00 CST 2013, time=2013-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262458, encodeId=16f1126245817, content=<a href='/topic/show?id=a57589339a4' target=_blank style='color:#2F92EE;'>#血液透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89339, encryptionId=a57589339a4, topicName=血液透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Wed Jul 24 04:29:00 CST 2013, time=2013-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570574, encodeId=0c2915e0574f4, content=<a href='/topic/show?id=e53d94835a5' target=_blank style='color:#2F92EE;'>#透析患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94835, encryptionId=e53d94835a5, topicName=透析患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0915676167, createdName=ewsr6, createdTime=Wed Jul 24 04:29:00 CST 2013, time=2013-07-24, status=1, ipAttribution=)]
    2013-07-24 habb

    #血液透析#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1643317, encodeId=9b09164331e82, content=<a href='/topic/show?id=6236895092b' target=_blank style='color:#2F92EE;'>#血管事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89509, encryptionId=6236895092b, topicName=血管事件)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99523187183, createdName=hukaixun, createdTime=Tue Oct 01 04:29:00 CST 2013, time=2013-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251451, encodeId=9262125145113, content=<a href='/topic/show?id=874529332ba' target=_blank style='color:#2F92EE;'>#全因死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=29332, encryptionId=874529332ba, topicName=全因死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Wed Jul 24 04:29:00 CST 2013, time=2013-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262458, encodeId=16f1126245817, content=<a href='/topic/show?id=a57589339a4' target=_blank style='color:#2F92EE;'>#血液透析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89339, encryptionId=a57589339a4, topicName=血液透析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19c567, createdName=habb, createdTime=Wed Jul 24 04:29:00 CST 2013, time=2013-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570574, encodeId=0c2915e0574f4, content=<a href='/topic/show?id=e53d94835a5' target=_blank style='color:#2F92EE;'>#透析患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94835, encryptionId=e53d94835a5, topicName=透析患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b0915676167, createdName=ewsr6, createdTime=Wed Jul 24 04:29:00 CST 2013, time=2013-07-24, status=1, ipAttribution=)]
    2013-07-24 ewsr6

    #透析患者#

    0

相关资讯

Heart：医疗远程监控或降心衰全因死亡

　　英国一项系统评价和荟萃分析表明，伴有医疗支持的结构性电话支持（STS）和家庭远程监控（TM）有益于出院患者，尤其可降低近期出院心衰患者的全因死亡率。论文5月16日在线发表于《心脏》（Heart）。 　　研究者对包括Medline、EMBASE和PsycINFO在内的14个数据库进行了检索，并纳入伴有同时期对照组的所有随机对照试验（RCT）或观察性队列研究。远程监控（RM）干预包括工办公时间或

JAMA:体重超重与较低死亡风险有关

　　美国一项研究显示，在一项对包括了大约300万名成年人的近100项研究的所做的分析显示，相对于正常体重而言，总体上的肥胖（将所有等级的肥胖结合在一起）及较严重的肥胖程度皆与显著的、更高的全因死亡风险有关，而体重超重则与显著较低的全因死亡率有关。1月2日《美国医学会杂志》（JAMA）上。 　　根据文章的背景资料：“对与正常体重、超重及肥胖相联系的相关死亡风险的估计可为临床决策提供帮助。” 　　

Diabetes Care:C肽水平与全因及心血管死亡独立相关

　　德国学者的一项研究表明，在接受冠脉造影的患者中，C肽水平与全因和心血管死亡率以及冠脉疾病严重度呈独立相关。论文于2012年11月30日在线发表于《糖尿病护理》（Diabetes Care）杂志。 　　C肽为胰腺释放的胰岛素原裂解产物。在胰岛素抵抗和早期糖尿病患者中C肽水平升高，并且C肽可能在血管疾病的病理生理学过程中发挥因果作用。此项研究共纳入2306例基线接受冠脉造影的患者，并对